Literature DB >> 8988175

Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis.

A Hemminki1, I Tomlinson, D Markie, H Järvinen, P Sistonen, A M Björkqvist, S Knuutila, R Salovaara, W Bodmer, D Shibata, A de la Chapelle, L A Aaltonen.   

Abstract

Many human cancer susceptibility genes have been successfully mapped by genetic linkage studies. One that has so far eluded researchers is that for Peutz-Jeghers (P-J) syndrome, a condition characterized by intestinal hamartomatous polyposis and melanin spots of the lips, buccal mucosa and digits. A dramatically elevated risk of malignancy has also been documented. Gastrointestinal tumours as well as cancers of the breast, ovary, testis and uterine cervix appear to be overrepresented in families with this syndrome. The nature of hamartomatous polyps is equivicol. Hamartomas are usually considered histologically benign, but in the case of Peutz-Jeghers patients, there are reports of adenomatous and malignant changes in the polyps, and the possibility of a hamartoma-carcinoma sequence has been discussed. A search for a putative tumour suppressor locus was made using comparative genomic hybridization (CGH) of Peutz-Jeghers polyps, combined with loss of heterozygosity (LOH) study. Genetic linkage analysis in 12 families using markers from a deletion site demonstrated the presence of a high-penetrance locus in distal 19p with a multipoint lod score of 7.00 at marker D19S886 without evidence of genetic heterogeneity. The study demonstrates the power of CGH combined with LOH analysis in identifying putative tumour suppressor loci, and provides molecular evidence of malignant potential in hamartomas.

Entities:  

Mesh:

Year:  1997        PMID: 8988175     DOI: 10.1038/ng0197-87

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  120 in total

1.  Inherited predisposition to pancreatic cancer.

Authors:  E Efthimiou; T Crnogorac-Jurcevic; N R Lemoine; T A Brentnall
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 2.  Anal squamous cell carcinoma in a patient with Peutz-Jeghers syndrome.

Authors:  B Mullhaupt; P Bauerfeind; M O Kurrer; M Fried
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

3.  Landscaper seeks remunerative position.

Authors:  R J Playford
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

4.  Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome.

Authors:  D C Connolly; H Katabuchi; W A Cliby; K R Cho
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 5.  Methods of molecular analysis: assessing losses and gains in tumours.

Authors:  R Roylance
Journal:  Mol Pathol       Date:  2002-02

Review 6.  Update on familial pancreatic cancer.

Authors:  H T Lynch; R E Brand; C A Deters; R M Fusaro
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 7.  Preventive measures in Peutz-Jeghers syndrome.

Authors:  D R McGrath; A D Spigelman
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

8.  Two novel STK11 missense mutations induce phosphorylation of S6K and promote cell proliferation in Peutz-Jeghers syndrome.

Authors:  Ran Li; Zhiqing Wang; Shu Liu; Baoping Wu; Di Zeng; Yali Zhang; Lanbo Gong; Feihong Deng; Haoxuan Zheng; Yadong Wang; Chudi Chen; Junsheng Chen; Bo Jiang
Journal:  Oncol Lett       Date:  2017-11-17       Impact factor: 2.967

Review 9.  Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.

Authors:  Henry T Lynch; Jane F Lynch; Patrick M Lynch; Thomas Attard
Journal:  Fam Cancer       Date:  2007-11-13       Impact factor: 2.375

10.  Restoration of silenced Peutz-Jeghers syndrome gene, LKB1, induces apoptosis in pancreatic carcinoma cells.

Authors:  Suparna Qanungo; Subrata Haldar; Aruna Basu
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.